Study links bisphosphonate use and root canal success
A new study has linked how long patients take bisphosphonate medication and the success of nonsurgical endodontic therapy. Researchers found patients who used zoledronate for less than one year had better outcomes than those who took the drug for longer. The retroactive study looked at outcomes one year after root canal therapy for patients who received intravenous zoledronate (Zometa, Novartis Pharmaceuticals). Patients who used zoledronate for less than one year



